PPAR-gamma agonist rosiglitazone stops the progressive dopaminergic degeneration induced by chronic MPTP in mice

被引：0
|
作者：
Carta, A. [1 ]
Frau, L. [1 ]
机构：
[1] Univ Cagliari, Toxicol, Cagliari, Italy
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70473-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.122
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [1] PPAR-GAMMA AGONIST ROSIGLITAZONE ALLEVIATES THE FIBROTIC PHENOTYPE OF SKIN SCLERODERMA FIBROBLASTS
    Kapoor, Mohit
    Shi-Wen, Xu
    Denton, Christopher P.
    Abraham, David J.
    Leask, Andrew
    WOUND REPAIR AND REGENERATION, 2009, 17 (04) : A70 - A70
  • [2] PPAR-Gamma agonist rosiglitazone is neuroprotective after stroke in type II diabetic rodents
    Vemuganti, R.
    Tureyen, K.
    Satriotomo, I.
    Bowen, K.
    Kapadia, R.
    Feinstein, D.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S253 - S253
  • [3] PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy
    Ziliani da Silva Buss
    Yara S. Medeiros
    Tania S. Fröde
    Inflammation, 2012, 35 : 280 - 288
  • [4] PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy
    Buss, Ziliani da Silva
    Medeiros, Yara S.
    Froede, Tania S.
    INFLAMMATION, 2012, 35 (01) : 280 - 288
  • [5] Effects of PPAR-gamma ligand rosiglitazone on liver fibrosis in chronic hepatitis C patients
    Passariello, N.
    Peluso, A.
    Passariello, G.
    Moniello, G.
    Maio, A.
    Mazo, S.
    Boccia, G.
    Esposito, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S237 - S237
  • [6] Targeting inflammation by PPAR-gamma agonist in LPS induced pulmonary dysfunction
    Sharma, R.
    Kaundal, R. K.
    Kumar, A.
    Sharma, S. S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 151 - 151
  • [7] Lipid profile and glucose tolerance during intervention with rosiglitazone, a PPAR-gamma agonist, in Brazilian obese subjects
    Barroso, SG
    Duarte, SFP
    Sanjuliani, AF
    Rodrigues, MLG
    Valença, DC
    Genelhu-Abreu, V
    Pimentel, MMG
    Francischetti, EA
    JOURNAL OF HYPERTENSION, 2004, 22 : S85 - S85
  • [8] A placebo-controlled trial of the insulin-sensitizing PPAR-gamma agonist rosiglitazone in patients with AD
    Craft, S
    Watson, GS
    Asthana, S
    Chapman, D
    Reger, M
    Baker, LD
    Hyde, K
    Cholerton, B
    Plymate, S
    Kahn, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S91 - S91
  • [9] Designer PPAR-gamma inverse agonist improves insulin sensitization in obese mice
    Hoekstra, WJ
    Trump, RP
    Lambert, MH
    Buckholz, RG
    Iannone, MA
    Harrington, WW
    Nolte, RT
    Cobb, JE
    Willson, TM
    Billin, AN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2641 - U2641
  • [10] Role of PPAR-gamma ligand rosiglitazone on the development of carrageenan-induced lung injury
    Cuzzocrea, S
    Dugo, L
    Di Paola, R
    Serraino, I
    Genovese, T
    Caputi, AP
    Thiemermann, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U20 - U20
12345